Cell-based Assays: Technologies and Global Markets

Published - Dec 2018| Analyst - Sathya Durga| Code - BIO080D
Cell-based Assays: Technologies and Global Markets
Single User License: $5500 Member Price: FREE

Report Highlights

The global market for cell-based assays should grow from $20.1 billion in 2018 to $32.7 billion by 2023 at a compound annual growth rate (CAGR) of 10.2% from 2018 through 2023.

Report Includes

  • 23 data tables and 48 additional tables
  • Detailed overview of the global market for cell-based assays within the industry
  • Analyses of global market trends with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Details of important assays, technologies and the latest developments and outlines market shares by assay type and company, with a special emphasis on the U.S. market
  • Regional dynamics of cell-based assays covering North America, Europe and other emerging economies
  • Examination of the cell-based assays available and currently being used, new developments, spending trends, and revenue prospects for cell-based assays in the pharmaceutical industry
  • Discussion of current issues and trends affecting the industry, as well as costs and factors that have an impact on demand
  • Coverage of major issues involved in the research and development (R&D) of more effective cell-based approaches for drug discovery
  • Company profiles of major players in the industry including Beckman Coulter, DiscoverX, PerkinElmer, Life Technologies and Promega Corp.

Report Scope

This report is an update of an earlier report of the same title. It reviews global markets and new developments for cell-based assays and forecasts trends for the use of these assays for drug discovery, safety and toxicology through 2023. The report includes details of important assays, technologies and the latest developments and outlines market shares by assay type and company, with a special emphasis on the U.S. market. Statistical information on the prevalence of types of cancers worldwide is also included.

The report also details current issues and trends affecting the industry, as well as costs and factors that have an impact on demand. It covers products in development, new technologies, trends, and alliances and mergers. The report offers market data by segment and region and discusses market trends with respect to drivers, restraints and opportunities.

Analyst Credentials

Sathya Durga has more than six years of domain experience. In addition to business research and consulting, she has conducted corporate briefings for top players in a wide range of market segments. She holds an MBA in marketing and finance from Chennai University and has worked with major market research firms.

Sathya Durga has authored several market research studies on subjects in the healthcare domain, including:

  • Healthcare tracking technologies.
  • Molecular diagnostics.
  • High-growth markets in healthcare and life sciences.
  • Adoption rates and analysis of over-the-counter (OTC) diabetes medicines and supplements.
  • Radio frequency identification (RFID), real-time locating systems (RTLS), internet protocol (IP) surveillance, and other emerging technologies in the healthcare domain.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - Jul-2017| Analyst - Usha Nagavarapu| Code - BIO080C

Report Highlights

The global market for cell-based assays reached $15.2 billion in 2015. This market is expected to increase from $17.1 billion in 2016 to nearly $28.4 billion in 2021 at a compound annual growth rate (CAGR) of 10.6% for 2016-2021.

Report Includes

  • An overview of the global markets and related technologies for cell-based assays.
  • Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Examinations of major issues involved in the research and development (R&D) of more effective cell-based approaches, for drug discovery and absorption, distribution, metabolism, and excretion (ADME)/ toxicity assays in development and in use.
  • The current market status of cell-based assays in terms of strengths, weaknesses, opportunities and threats facing various assays and developments already on the market.
  • Discussion of current issues and trends affecting the industry, and costs and other factors influencing demand.
  • Coverage of new technologies, trends, alliances, and mergers.
  • Profiles of major players in the industry.
Published - Apr-2014| Analyst - Usha Nagavarapu| Code - BIO080B

Report Highlights

BCC Research estimates that the global market for cell-based assays will increase at a compound annual growth rate (CAGR) of 12.4% over the next five years to reach $15.2 billion in 2015 and $21.6 billion by 2018 from $12.1 billion in 2013.

Report Includes

  • An overview of the global market for cell-based assays available and currently used.
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Examinations of major issues involved in the research and development (R&D) of more effective cell-based approaches, for drug discovery, and absorption, distribution, metabolism, and excretion (ADME)/ toxicity assays in development and in use.
  • Discussion of current issues and trends affecting the industry, and costs and other factors influencing demand.
  • Coverage of new technologies, trends, alliances, and mergers.
Published - May-2011| Analyst - Usha Nagavarapu| Code - BIO080A

Report Highlights

Cell biology is currently the biggest revenue contributor to the life-science tools industry, accounting for approximately 30% of total sales.  It is expected to grow to a $15 billion market by 2015, increasing at a compound annual growth rate (CAGR) of 12.3% from its 2010 value of $8.5 billion.

CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report